Company / Operating Cash Flow per Share
Medpace Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$23.28
FY2025
5-year range
$7.18 / $23.28
FY2021-FY2025
Trend
+17.6%
vs FY2024
Sector context
#9 of 161
Health Care
What the data says
Among 161 Health Care companies, Medpace is in the top 6% for operating cash flow per share. Operating Cash Flow per Share has increased for 3 consecutive years, from $7.18 in FY2022 to $23.28 in FY2025.
Based on SEC 10-K filings.
23.28 in FY2025 with a 5-year CAGR of +26.6%. Top quartile in the Health Care sector.
Improved from $13.94 to $23.28 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +48.0%
- 5-Year CAGR
- +26.6%
- 10-Year CAGR
- -
Sector benchmark
+250.5% above sector average
Key checks
Key Insights
- Medpace's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 17.6% year-over-year.
- Ranks #9 out of 161 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.28 | +17.6% |
| FY2024 | $19.80 | +42.0% |
| FY2023 | $13.94 | +94.0% |
| FY2022 | $7.18 | -3.1% |
| FY2021 | $7.41 | +3.4% |
| FY2020 | $7.17 | +26.7% |
| FY2019 | $5.66 | +118.8% |
| FY2018 | $2.59 | +8.0% |
| FY2017 | $2.39 | -14.8% |
| FY2016 | $2.81 | +2.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026